Is genetic screening necessary for determining the possibility of venous thromboembolism in cancer patients?

Medical Principles and Practice

Volumn 21, Issue 2, 2012, Pages 160-163

  Onur, Ece ^a   Kurdal, Adnan Taner ^b   Tugrul, Berrin ^b   Iskesen, Ihsan ^b   Dundar, Pinar ^b   Taneli, Fatma ^a   Ulman, Cevval ^a   Var, Ahmet ^a  

^a Departments of Biochemistry   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Cancer; Mutation; Polymorphism; Venous thromboembolism

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HUMAN; MALE; RISK; VENOUS THROMBOEMBOLISM;

DISEASE SUSCEPTIBILITY; FEMALE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, GENETIC; VENOUS THROMBOEMBOLISM;

EID: 84857361698     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000333394     Document Type: Article

References (18)

1. Blann AD, Lip GY: Virchow's triad revisited: The importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res 2001; 101: 321-327. (Pubitemid 32206588)
2. de Stefano V, Finazzi G, Mannucci PM: Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-3544. (Pubitemid 26129579)
3. Seligsohn U, Zivelin A: Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78: 297-301. (Pubitemid 27289257)
4. Prandoni P, Piccioli A, Girolami A: Cancer and venous thromboembolism: An overview. Haematologica 1999; 84: 437-445. (Pubitemid 29473135)
5. Prandoni P: Antithrombotic strategies in patients with cancer. Thromb Haemost 1997; 78: 141-144. (Pubitemid 27289232)
6. Donati MB, Falanga A: Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 2001; 106: 18-24. (Pubitemid 32830512)
7. Gale AJ, Gordon SG: Update on tumor cell procoagulant factors. Acta Haematol 2001; 106: 25-32. (Pubitemid 32830513)
8. Ramacciotti E, Wolosker N, Puech-Leao P, Zeratti EA, Gusson PR, del Giglio A, Franco RF: Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis. Thromb Res 2003; 109: 171-174. (Pubitemid 36712904)
9. Otrock ZK, Taher AT, Shamseddeen WA, Zaatari G, Bazarbachi A, Mahfouz RA: Factor V HR2 haplotype: A risk factor for venous thromboembolism in individuals with absence of Factor V Leiden. Ann Hematol 2008; 87: 1013-1016.
10. Spiroski I, Kedev S, Antov S, Arsov T, Krstevska M, Dzhekova-Stojkova S, Bosilkova G, Kostovska S, Trajkov D, Petlichkovski A, Strezova A, Efinska-Mladenovska O, Spiroski M: Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis. Acta Biochim Pol 2008; 55: 587-594.
11. Akhter M, Biswas A, Ranjan R, Meena A, Yadav B, Sharma A, Saxena R: Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost 2010; 16: 184-188.
12. Xenophontos SL, Hadjivassiliou M, Ayrton N, Karagrigoriou A, Pantzaris M, Nicolaides AN, Cariolou MA: Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population. Int Angiol 2002; 21: 322-329. (Pubitemid 36322368)
13. Var A, Utük O, Akçaliu S, Sanlidag T, Uyanik BS, Dinç G: Impact of hemostatic gene single point mutations in patients with non-diabetic coronary artery disease. Mol Biol Rep 2009; 36: 2235-2243.
14. Decousus H, Moulin N, Quenet S, Bost V, Guillot KR, Laporte S, Mismetti P: Thrombophilia and risk of venous thrombosis in patients with cancer. Thromb Res 2007; 120(suppl 2):S51-S61. (Pubitemid 350101772)
15. Kennedy M, Andreescu AC, Greenblatt MS, Jiang H, Thomas CA, Chassereau L, Wong C, Durda P, Cushman M: Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients. Br J Haematol 2005; 128: 386-388. (Pubitemid 40216162)
16. Otterson GA, Monahan BP, Harold N, Steinberg SM, Frame JN, Kaye FJ: Clinical significance of the FV:Q 506 mutation in unselected oncology patients. Am J Med 1996; 101: 406-412. (Pubitemid 26392859)
17. Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ: The Factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 1997; 96: 484-489. (Pubitemid 27087231)
18. Eroglu A, Ulu A, Cam R, Kurtman C, Akar N: Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients. J Thromb Thrombolysis 2007; 23: 31-34.